FDA Approves First Nasal Spray to Treat Anaphylaxis

The new nasal spray may help people with a fear of needles like those in EpiPens.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

On Friday, the U.S. Food and Drug Administration (FDA) approved neffy, a nasal spray for the emergency treatment of allergic reactions, including life-threatening anaphylactic shock.

The spray is approved for use in adults and children who weigh at least 66 pounds (30 kilograms). It was greenlighted through one of the FDA’s drug expedition processes.